Cardinal Health (CAH) Updates FY23 Guidance and Provides FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Cardinal Health Investor Day to Highlight Long-Term Value Creation
June 8, 2023 6:54 AM EDTNarrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80, from $5.60 to $5.80 (13% growth at the mid-point)1Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance of $6.45 to $6.70 (15% growth at the mid-points)Providing long-term financial targets reflecting 12% to 14% growth of non-GAAP diluted EPS (3-year CAGR)2Raising long-term financial target for Pharmaceutical segment profit to 4% to 6% growth, from "low-single digit to mid-single digit" growthUpdating Medical Improvement Plan timeline for $650M+ in segment profit to... More
